Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.

Home > Anti-aging Research > Chemotherapy > Erbitux (cetuximab)

Erbitux® (IMC-C225, cetuximab)

Related Topics:

• 5-Fluorouracil / Angiostatin, Endostatin & other anti-angiogenesis drugs / Alimta (pemetrexed) / Aptosyn (exisulind) / Avastin™ (bevacizumab, rhuMAb-VEGF) / Bondronat® (ibandronate) / Campto (irinotecan) / Doxil (doxorubicin HCl) / Eloxatin (oxaliplatin) / Erbitux® (IMC-C225, cetuximab) / Gleevec (imatinib) / Gemzar (gemcitabine) / Herceptin (trastuzumab) / Hycamtin (topotecan) / Iressa (gefitinib) / Ixempra(TM) (ixabepilone) / Navelbine (vinorelbine) / Paraplatin (carboplatin) / Platinol (cisplatin) / Rituxan (rituximab) / satraplatin / Taxol (paclitaxel) / Taxotere (docetaxel) / thalidomide / Torisel (temsirolimus) / Tykerb (lapatinib) / Xeloda (capecitabine)

News & Research:

• Cetuximab Increases Survival In Advanced Colorectal Cancer Patients - Science Daily, 4/19/07
• New Drug May Help Prolong Survival For Head And Neck Cancer Patients - Science Daily, 1/19/07
• FDA OKs Drug for Head & Neck Cancer - WebMD, 3/2/06
• FDA Approves Erbitux (Cetuximab), First Head & Neck Cancer Treatment in 45 Years - Doctor's Guide, 3/2/06
• Erbitux Proven Effective in Locoregional Squamous Cell Carcinoma of the Head and Neck - Doctor's Guide, 11/17/05
• New Warning Issued for Colorectal Drug - Intelihealth, 9/15/05
• Cetuximab Shows Promise for Locally Advanced Non-small-cell Lung Cancer - Doctor's Guide, 11/15/04
• Erbitux (Cetuximab) Appears to Slow Disease Progression in Metastatic Colorectal Cancer - Doctor's Guide, 7/22/04
• Adding Erbitux (Cetuximab) to Radiation Improves Survival in Patients with Head and Neck Cancer - Doctor's Guide, 6/6/04
• Erbitux (Cetuximab) Receives FDA Approval to Treat Irinotecan Refractory Or Intolerant Metastatic Colorectal Cancer - Doctor's Guide, 2/13/04

Related Searches:

• Doctor's Guide search of Erbitux or cetuximab
• Doctor's Guide (2) search of cetuximab
• Life Extension Foundation search
• Medline search of cetuximab
• Medscape search of Erbitux or cetuximab
• Nutrition Science News search
• RxList search of cetuximab
• WebMD search of cetuximab

70524